110 results in Exploration of Neuroprotective Therapy
Most Cited
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Review
Striking a balance: PIP2 and PIP3 signaling in neuronal health and disease
Kamran Tariq, Bryan W. Luikart
Published: October 29, 2021 Explor Neuroprot Ther. 2021;1:86–110
This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases
Open Access
Review
Blocking cholesterol storage to treat Alzheimer’s disease
Ta Yuan Chang ... James G. Gow
Published: December 30, 2021 Explor Neuroprot Ther. 2021;1:173–184
This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases
Open Access
Review
Advancing diagnosis and treatment of Niemann-Pick C disease through biomarker discovery
Xuntian Jiang, Daniel S. Ory
Published: December 30, 2021 Explor Neuroprot Ther. 2021;1:146–158
This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases
Open Access
Review
Pathophysiology of non-motor signs in Parkinson’s disease: some recent updating with brief presentation
Khaled Radad ... Wolf-Dieter Rausch
Published: February 27, 2023 Explor Neuroprot Ther. 2023;3:24–46
This article belongs to the special issue Parkinsons Disease: Principal Targets and Interventional Mechanisms
Open Access
Review
Subarachnoid hemorrhage: management considerations for COVID-19
Eric J. Panther, Brandon Lucke-Wold
Published: March 02, 2022 Explor Neuroprot Ther. 2022;2:65–73
This article belongs to the special issue Emerging Concepts in Subarachnoid Hemorrhage
Open Access
Review
Balancing cholesterol in the brain: from synthesis to disposal
Lydia Qian ... Andrew J. Brown
Published: January 05, 2022 Explor Neuroprot Ther. 2022;2:1–27
This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases
Open Access
Review
The glymphatic system and subarachnoid hemorrhage: disruption and recovery
Stephan Quintin ... Brandon Lucke-Wold
Published: June 21, 2022 Explor Neuroprot Ther. 2022;2:118–130
This article belongs to the special issue Emerging Concepts in Subarachnoid Hemorrhage
Open Access
Review
Biomarkers in neurodegenerative diseases: a broad overview
Sathish Selvam, Velpandi Ayyavoo
Published: April 16, 2024 Explor Neuroprot Ther. 2024;4:119–147
This article belongs to the special issue The Future of Biomarkers in CNS Diseases
Open Access
Review
Targeting α-synuclein aggregation with immunotherapy: a promising therapeutic approach for Parkinson’s disease
Gabriela Henriquez, Mahesh Narayan
Published: August 25, 2023 Explor Neuroprot Ther. 2023;3:207–234
This article belongs to the special issue Parkinsons Disease: Principal Targets and Interventional Mechanisms
Open Access
Review
T-cell based immunotherapies for Parkinson’s disease
Rodrigo Pacheco
Published: October 29, 2021 Explor Neuroprot Ther. 2021;1:72–85
Open Access
Review
Economics of dry needling and botulinum toxin type A for treatment of post-stroke spasticity: a review
Daniel Fernández ... Eva María Gómez-Trullén
Published: June 30, 2022 Explor Neuroprot Ther. 2022;2:131–140
This article belongs to the special issue Dry Needling for Neurological Disorders
Open Access
Systematic Review
Various facets of excitotoxicity
Talita Glaser ... Henning Ulrich
Published: February 23, 2022 Explor Neuroprot Ther. 2022;2:36–64
Open Access
Perspective
Gut microbiota could modulate the effects of neuro-immune responses and memory traces via the gut-brain-immune axis in schizophrenia
Haruka Sawamura ... Satoru Matsuda
Published: April 24, 2022 Explor Neuroprot Ther. 2022;2:74–86
This article belongs to the special issue Intervention of Neuroimmune Responses
Open Access
Review
Exploration of transcutaneous vagus nerve stimulation as a treatment option for adjuvant cancer and heart failure therapy
Niklas Frank ... Carola Y. Förster
Published: October 31, 2023 Explor Neuroprot Ther. 2023;3:363–397
This article belongs to the special issue Intervention of Neuroimmune Responses
Open Access
Review
Neuroprotective astroglial response to neural damage and its relevance to affective disorders
José Javier Miguel-Hidalgo
Published: October 31, 2023 Explor Neuroprot Ther. 2023;3:328–345
Open Access
Review
Can chronic therapeutic drug use by the elderly affect Alzheimer’s disease risk and rate of progression?
Rafael Franco, Joan Serrano-Marín
Published: February 27, 2023 Explor Neuroprot Ther 2023;3:8–23
This article belongs to the special issue The Urgent Need for New Hypotheses to Develop Effective Therapeutic Tools Against Alzheimers Disease
Open Access
Review
Potentialities of IGF-1 for regulating oxidative stress in neuroinflammation and neurodegeneration: theoretical review
Macarena Lorena Herrera ... Claudia Beatriz Hereñú
Published: October 31, 2024 Explor Neuroprot Ther. 2024;4:442–458
Open Access
Review
Targeting cytochrome P450 46A1 and brain cholesterol 24-hydroxylation to treat neurodegenerative diseases
Irina A. Pikuleva
Published: December 30, 2021 Explor Neuroprot Ther. 2021;1:159–172
This article belongs to the special issue Cholesterol Dyshomeostasis in Neurological Diseases
Open Access
Original Article
Combined effects of dry needling and exercises therapy on muscle spasticity and motor function in chronic stroke: a pretest-posttest pilot study
Seyedeh Saeideh Babazadeh-Zavieh ... Korosh Mansoori
Published: June 20, 2022 Explor Neuroprot Ther. 2022;2:100–109
This article belongs to the special issue Dry Needling for Neurological Disorders
Open Access
Perspective
Can meditation-based approaches improve the cleansing power of the glymphatic system?
Peter Wostyn, Piet Goddaer
Published: June 20, 2022 Explor Neuroprot Ther. 2022;2:110–117
Journal Information